A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Body weight ≥ 45 kg and ≤ 120 kg * BMI ≥ 18 kg/m\^2 and ≤ 35 kg/m\^2 * Heart rate ≥ 50 bpm and \< 95 bpm * Stable renal impairment, defined as no clinically significant change in disease status, as documented by the subject's most recent eGFR assessment * No changes in medication within 30 days prior to study drug administration Exclusion Criteria: * Clinically relevant abnormal medical history, abnormal findings on physical examination, vital signs, ECG, or laboratory tests * History of chronic headaches, defined as occurring 15 days or more a month, over the previous 3 months * History of headaches related to caffeine withdrawal * History of migraine or cluster headaches * Patients requiring dialysis will not be enrolled in this study Other protocol defined inclusion/exclusion criteria could apply